As Natus Medical Del (BABY) Share Price Declined, Holder Rainier Investment Management Lifted Holding; American Research & Management Stake In Coca Cola Company (KO) Was Has Upped

April 22, 2018 - By Michael Collier

The Coca-Cola Company (NYSE:KO) Logo

Rainier Investment Management Llc increased its stake in Natus Medical Inc Del (BABY) by 25.74% based on its latest 2017Q4 regulatory filing with the SEC. Rainier Investment Management Llc bought 17,030 shares as the company’s stock declined 13.23% with the market. The institutional investor held 83,180 shares of the electromedical & electrotherapeutic apparatus company at the end of 2017Q4, valued at $3.18M, up from 66,150 at the end of the previous reported quarter. Rainier Investment Management Llc who had been investing in Natus Medical Inc Del for a number of months, seems to be bullish on the $1.18 billion market cap company. The stock decreased 0.41% or $0.15 during the last trading session, reaching $36.1. About 198,654 shares traded. Natus Medical Incorporated (NASDAQ:BABY) has declined 13.34% since April 22, 2017 and is downtrending. It has underperformed by 24.89% the S&P500.

American Research & Management increased its stake in Coca Cola Company (KO) by 14.22% based on its latest 2017Q4 regulatory filing with the SEC. American Research & Management bought 6,751 shares as the company’s stock declined 5.92% with the market. The institutional investor held 54,228 shares of the beverages (production and distribution) company at the end of 2017Q4, valued at $2.49 million, up from 47,477 at the end of the previous reported quarter. American Research & Management who had been investing in Coca Cola Company for a number of months, seems to be bullish on the $186.53B market cap company. The stock decreased 1.29% or $0.57 during the last trading session, reaching $43.74. About 14.69 million shares traded or 10.41% up from the average. The Coca-Cola Company (NYSE:KO) has risen 1.35% since April 22, 2017 and is uptrending. It has underperformed by 10.20% the S&P500.

Since January 16, 2018, it had 0 buys, and 5 sales for $6.52 million activity. On Monday, March 12 the insider MANN JENNIFER K sold $84,735. 14,129 shares valued at $631,572 were sold by MURPHY JOHN on Tuesday, March 13. Another trade for 15,000 shares valued at $719,250 was sold by LONG ROBERT EDWARD. 23,240 shares were sold by Waller Kathy N, worth $1.07M.

Investors sentiment increased to 0.91 in Q4 2017. Its up 0.11, from 0.8 in 2017Q3. It increased, as 51 investors sold KO shares while 623 reduced holdings. 124 funds opened positions while 492 raised stakes. 2.73 billion shares or 0.05% less from 2.73 billion shares in 2017Q3 were reported. Grimes And stated it has 18,288 shares. Salem Inv Counselors has 0.67% invested in The Coca-Cola Company (NYSE:KO). Chicago Equity Ptnrs Ltd Limited Liability Company reported 283,005 shares or 0.4% of all its holdings. Liberty Mgmt Inc, Michigan-based fund reported 3,607 shares. Associated Banc holds 0.51% of its portfolio in The Coca-Cola Company (NYSE:KO) for 204,547 shares. Elm Limited Liability accumulated 13,055 shares. Fairfield Bush stated it has 0.22% in The Coca-Cola Company (NYSE:KO). Qci Asset Mgmt Ny invested in 0.02% or 4,261 shares. Plancorp Llc reported 7,398 shares. South State Corporation stated it has 254,897 shares or 1.26% of all its holdings. Cramer Rosenthal Mcglynn Ltd Liability accumulated 8,000 shares. S&Co reported 6,635 shares. Pennsylvania Trust Com owns 145,594 shares for 0.3% of their portfolio. Ar Asset Mgmt has 174,615 shares. 33,028 are held by Fruth Investment Mngmt.

Among 22 analysts covering Coca-Cola (NYSE:KO), 12 have Buy rating, 0 Sell and 10 Hold. Therefore 55% are positive. Coca-Cola had 76 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Morgan Stanley with “Equal-Weight” on Thursday, October 26. Credit Suisse maintained The Coca-Cola Company (NYSE:KO) on Tuesday, February 20 with “Outperform” rating. The company was downgraded on Thursday, January 19 by Wells Fargo. Goldman Sachs maintained The Coca-Cola Company (NYSE:KO) rating on Thursday, April 21. Goldman Sachs has “Neutral” rating and $47 target. The stock of The Coca-Cola Company (NYSE:KO) earned “Buy” rating by Bank of America on Monday, October 9. The firm has “Hold” rating given on Thursday, January 4 by Jefferies. The stock has “Neutral” rating by Jefferies on Wednesday, April 19. As per Monday, July 24, the company rating was maintained by Jefferies. The rating was maintained by UBS on Thursday, April 21 with “Buy”. Jefferies maintained the stock with “Hold” rating in Tuesday, September 5 report.

Rainier Investment Management Llc, which manages about $7.08B and $236.50M US Long portfolio, decreased its stake in Palo Alto Networks Inc (NYSE:PANW) by 4,160 shares to 16,700 shares, valued at $2.42 million in 2017Q4, according to the filing. It also reduced its holding in Oshkosh Corp (NYSE:OSK) by 29,990 shares in the quarter, leaving it with 57,310 shares, and cut its stake in Mdu Res Group Inc (NYSE:MDU).

Since March 2, 2018, it had 0 insider purchases, and 1 sale for $126,700 activity.

Among 5 analysts covering Natus Medical (NASDAQ:BABY), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Natus Medical had 11 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was maintained by Roth Capital with “Buy” on Tuesday, April 5. The rating was downgraded by William Blair to “Hold” on Monday, January 8. The stock of Natus Medical Incorporated (NASDAQ:BABY) has “Outperform” rating given on Tuesday, September 13 by Raymond James. The firm earned “Buy” rating on Tuesday, January 12 by TH Capital. The company was maintained on Tuesday, February 27 by Roth Capital. TH Capital maintained it with “Buy” rating and $51 target in Thursday, July 23 report. The firm has “Buy” rating given on Monday, September 11 by Roth Capital. The rating was maintained by TH Capital with “Buy” on Thursday, October 22. On Thursday, February 2 the stock rating was downgraded by Raymond James to “Mkt Perform”. The stock has “Buy” rating by Benchmark on Tuesday, October 4.

Natus Medical Incorporated (NASDAQ:BABY) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>